Φορτώνει......
B cell and B cell-related pathways for novel cancer treatments
B cells are recognized as the main effector cells of humoral immunity which suppress tumor progression by secreting immunoglobulins, promoting T cell response, and killing cancer cells directly. Given these properties, their anti-tumor immune response in the tumor micro-environment (TME) is of great...
Αποθηκεύτηκε σε:
| Τόπος έκδοσης: | Cancer Treat Rev |
|---|---|
| Κύριοι συγγραφείς: | , , , , , , , , , |
| Μορφή: | Artigo |
| Γλώσσα: | Inglês |
| Έκδοση: |
2018
|
| Θέματα: | |
| Διαθέσιμο Online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7505165/ https://ncbi.nlm.nih.gov/pubmed/30551036 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.ctrv.2018.12.001 |
| Ετικέτες: |
Προσθήκη ετικέτας
Δεν υπάρχουν, Καταχωρήστε ετικέτα πρώτοι!
|